Report says: MphasiS attains growth rate of 20% in Life Sciences AO

MphasiS has announced that it has been named as a major contender in the life sciences application outsourcing space by Everest Group. For specialization and innovative models across its Life Sciences domain, MphasiS has been recognized in Everest Group's PEAK Matrix report titled "IT application Outsourcing (AO) in the Life Sciences Industry - Service Provider Landscape".

Rajesh Makhija, Sr. Vice-President & Head, Enterprise Market Unit, said, "We are delighted to have been named as a major contender in providing solutions to the U.S.-based pharma and biotech companies. We registered a growth rate of over 20% in life sciences AO revenue last year. MphasiS has proven its operational capabilities in life sciences delivering by multiple proprietary solutions and alliances in this space. We will continue to invest in this vertical to further develop our benchmark in the industry."

"The healthcare and life sciences market continues to grow rapidly and a number of service providers are making focussed investments to develop their offerings for this vertical. A combination of domain expertise, cross-leveraging the healthcare and life sciences technology eco-system and the ability to connect the dots of regulation and innovation have emerged as winning themes in the marketplace. MphasiS' demonstrated capabilities across several of these attributes coupled with its alliances helped it achieve its positioning as Major Contender," said Jimit Arora, Vice-President, Everest Group.

The research report in particular recognizes IT application outsourcing service providers specific to the global life sciences arena. MphasiS was assessed among 14 other leading life sciences AO service providers across three distinct categories that include global majors, offshore majors and regional/ tier-2 players.